Publications by authors named "Hiroaki Ikematsu"

Introduction: Cell-free and concentrated ascites reinfusion therapy (CART) is frequently used to relieve the symptoms caused by massive ascites due to peritoneal metastasis of gastric cancer, especially in the later stages of its clinical course. Irinotecan (CPT-11) is recommended for third- or later-line chemotherapy according to gastric cancer treatment guidelines. However, the concentrations of anti-cancer drugs in the ascites and the product of CART are not well known, it is considered that some amounts of anti-cancer drugs contained in the product of CART may be readministered and induce severe adverse reactions.

View Article and Find Full Text PDF

A comprehensive endoscopic small and large intestinal untargeted step biopsy procedure was conducted to compare gene expression between the normal intestinal mucosa of healthy individuals and that of patients with colorectal tumors. From 78 participants (healthy individuals [n = 17], patients with colorectal conventional adenomas [n = 6], patients with Tis-T1 colorectal cancer [n = 41], patients with T2-4 colorectal cancer [n = 14]), biopsies of normal mucosa of the terminal ileum, right-sided colon (cecum and ascending colon), and left-sided colorectum (descending colon, sigmoid colon, and rectum) were obtained using a lower gastrointestinal endoscope. RNA was extracted from all samples, and total transcriptome sequencing was performed.

View Article and Find Full Text PDF

Background And Aim: The risk of colorectal cancer among fecal immunochemistry test-positive individuals who had undergone previous colonoscopies remains unclear. Therefore, this study aimed to determine the differences in the risk of colorectal cancer among fecal immunochemistry test-positive individuals according to the timing of their previous colonoscopies.

Methods: This multicenter, retrospective, observational study was conducted in Japan as a subgroup analysis of the J-SCOUT study (UMIN000040690), which integrated and analyzed a database comprising all colonoscopies performed at participating Japanese institutions between 2010 and 2020.

View Article and Find Full Text PDF

Background: Fecal immunochemical tests are commonly performed for colorectal cancer screening. Instant fecal occult blood measurement in toilet bowel movements would improve convenience. Hyperspectral imaging (HSI) enables the nondestructive evaluation of materials that are difficult to assess visually.

View Article and Find Full Text PDF

Objectives: Few reports have detailed improvements in the quality of colonoscopies with continuous training post-fellowship completion. We examined the changes in colonoscopy performance among trainees during our advanced endoscopy training program.

Methods: Screening or surveillance colonoscopies performed by 11 trainees who participated in our 3-year advanced endoscopy training program between April 2015 and March 2020 were retrospectively analyzed.

View Article and Find Full Text PDF

In submucosal invasive adenocarcinoma of the esophagogastric junction (pT1b-SM AEG), the extent of tumor submucosal (SM) invasion is measured using the vertical depth of SM invasion with the muscularis mucosa. This study aimed to investigate whether tumor thickness and depth of invasion without accounting for muscularis mucosa were superior to the vertical depth of SM invasion as metastasis predictors. We enrolled patients with pT1b-SM AEG who underwent endoscopic resection or surgical resection (SR) at our institution between January 2011 and September 2019 and were followed up for ≥2 years.

View Article and Find Full Text PDF
Article Synopsis
  • * A total of 82,005 colonoscopy cases were analyzed, revealing 71 identified colorectal NENs, which corresponds to a detection rate of 0.087%. Most cases were small lesions in the rectum.
  • * Findings suggest that the detection rate of colorectal NENs during colonoscopy is higher than previously anticipated, indicating the importance of thorough screening.
View Article and Find Full Text PDF
Article Synopsis
  • Endoscopic resection (ER) is commonly used for early colorectal cancer, but the need for further surgery in cases of pathological T1 colorectal cancer (pT1CRC) is debated due to uncertain risks of lymph node metastasis (LNM).
  • This study analyzed 600 pT1CRC patients to explore the clinicopathological characteristics and LNM risk for those with lymphoid follicular replacement (LFR).
  • Findings revealed that 6.7% of patients had pT1CRC with LFR, and notably, none experienced LNM during a median follow-up of 61 months, suggesting that patients with LFR might not require additional surgical intervention even with deeper submucosal invasion.
View Article and Find Full Text PDF

Purpose: As long-term survival improves after allogeneic hematopoietic stem cell transplantation (HSCT), the risk for secondary solid cancers, including colon cancer, also increases. However, the pathogenesis of secondary solid cancers in post-HSCT patients remains unclear. This study aimed to investigate the involvement of local immunity in colon carcinogenesis in post-HSCT patients by assessing the infiltrating T cells in colon adenomas as premalignant lesions of colon cancer in adenoma-carcinoma sequence.

View Article and Find Full Text PDF

Objectives: This study investigated the incidence of lymph node metastasis and long-term outcomes in patients with T1 colorectal cancer where endoscopic submucosal dissection (ESD) resulted in noncurative treatment. It is focused on those with deep submucosal invasion, a factor considered a weak predictor of lymph node metastasis in the absence of other risk factors.

Methods: This nationwide, multicenter, prospective study conducted a post-hoc analysis of 141 patients with T1 colorectal cancer ≥20 mm where ESD of the lesion resulted in noncurative outcomes, characterized by poor differentiation, deep submucosal invasion (≥1000 μm), lymphovascular invasion, high-grade tumor budding, or positive vertical margins.

View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the effectiveness of a noninvasive assay (Guardant Reveal) that detects circulating tumor DNA (ctDNA) in patients with resected colorectal cancer, which can predict recurrence without needing prior tissue tests.
  • Results showed that the assay provided sensitive and specific detection of minimal disease, with an impressive 81% sensitivity in later-stage colon cancer, and identified recurrences up to 5.3 months earlier than traditional methods.
  • The findings suggest that ctDNA testing could significantly enhance clinical management for stage II and higher colorectal cancer patients by offering a quicker and more accessible way to assess disease status.
View Article and Find Full Text PDF

Objectives: Colonoscopy (CS) is an important screening method for the early detection and removal of precancerous lesions. The stool state during bowel preparation (BP) should be properly evaluated to perform CS with sufficient quality. This study aimed to develop a smartphone application (app) with an artificial intelligence (AI) model for stool state evaluation during BP and to investigate whether the use of the app could maintain an adequate quality of CS.

View Article and Find Full Text PDF

Objectives: For early gastrointestinal lesions, size is an important factor in the selection of treatment. Virtual scale endoscope (VSE) is a newly developed endoscope that can measure size more accurately than visual measurement. This study aimed to investigate whether VSE measurement is accurate for early gastrointestinal lesions of various sizes and morphologies.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the long-term outcomes, specifically overall survival (OS), of patients with T1 colorectal cancer (CRC) who underwent endoscopic resection (ER) followed by additional surgery (AS) compared to those who had primary surgery (PS) alone.
  • It involved analyzing data from 6,105 patients treated at various high-volume Japanese institutions and utilized propensity score matching to ensure comparability between the two groups.
  • The findings suggested that patients who underwent AS after ER had a 5-year OS rate of 97.1%, comparable to 96.0% for the PS group, indicating that ER before AS does not adversely affect long-term outcomes.
View Article and Find Full Text PDF

Colonoscopy is the gold standard for detecting and resecting adenomas or early stage cancers to reduce the incidence and mortality rates of colorectal cancer. In a recent observational study, texture and color enhancement imaging (TXI) was reported to improve polyp detection during colonoscopy. This randomized controlled trial involving six Japanese institutions aims to confirm the superiority of TXI over standard white-light imaging (WLI) in detecting colorectal lesions during colonoscopy.

View Article and Find Full Text PDF

Background: Endoscopic submucosal dissection (ESD) can be performed for superficial esophageal cancer. However, performing ESD for superficial esophageal cancer on a previous endoscopic resection scar may be difficult.

Methods: We compared the outcomes between ESD for superficial esophageal cancers on previous endoscopic resection scar (group A) and that for naïve lesions (group B).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the proportions and characteristics of different types of colorectal cancer (CRC), specifically interval CRC (iCRC) and postcolonoscopy CRC (PCCRC), using data collected from adult patients in Japan.
  • A total of 1,241 CRC patients were surveyed, revealing that annual FIT-iCRC accounted for 4.5%, 3-year PCCRC 7.0%, and CRC detected after noncompliance to colonoscopy 3.9% of all CRC cases.
  • The findings indicated that iCRC and PCCRC exhibited distinct biological features, including higher rates of right-sided tumors, a greater proportion of female patients, and increased BRAF mutation rates compared to other CRC types.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined 354 patients with primary small bowel adenocarcinoma (PSBA) in Japan, revealing a median age of 67 years and a majority being male (61.6%).
  • The majority of tumors were located in the jejunum (66.2%) and ileum (30.4%), with over 76% of patients presenting symptoms at diagnosis, often at an advanced stage.
  • The research found that clinical stage was the main predictor of disease-specific survival, emphasizing the importance of early detection for better patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effectiveness of pathological criteria from the JSCCR guidelines for determining the need for additional treatment in patients with pT1 colorectal carcinoma who had undergone local resection.
  • Researchers analyzed data from 4,667 patients and found that those with risk factors for lymph node metastasis had a significantly higher incidence of metastasis and recurrence, while those without risk factors had excellent survival rates.
  • Overall, the findings support the JSCCR criteria, highlighting their importance in identifying low-risk patients who can expect favorable outcomes post-resection.
View Article and Find Full Text PDF
Article Synopsis
  • Endoscopic resection is a common local treatment for small rectal neuroendocrine tumors, but there's no clear consensus on the best method, prompting a comparison of two techniques: ESD and ESMR-L.
  • The study is a prospective, multicenter, randomized trial involving 266 patients, evaluating the effectiveness of ESMR-L versus ESD, with the main goal of determining if ESMR-L offers similar rates of complete tumor removal (R0 resection).
  • This trial will also assess additional factors like procedure time, costs, and complications, contributing to understanding the best approach for treating these tumors.
View Article and Find Full Text PDF
Article Synopsis
  • This study explored the characteristics and outcomes of stage IV small bowel adenocarcinoma (SBA) in Japan, analyzing data from 128 patients to determine the effectiveness of different treatment strategies.
  • The treatments included chemotherapy alone, surgery alone, surgery combined with chemotherapy, and best supportive care, revealing a median overall survival of 16 months, with the best outcomes seen in those receiving surgery and chemotherapy.
  • Results indicated that patients who underwent surgery or chemotherapy had better survival rates compared to those with best supportive care, and survival did not significantly vary among different chemotherapy regimens.
View Article and Find Full Text PDF
Article Synopsis
  • The study compares two bowel cleansing methods for colonoscopy preparation: Sodium picosulfate/magnesium citrate (SP/MC) and polyethylene glycol (PEG) with ascorbic acid, with a focus on patient acceptability and effectiveness.
  • The trial includes 540 participants aged 40-69 and evaluates bowel cleansing quality using the Boston Bowel Preparation Scale, along with other factors like patient satisfaction and detection of polyps.
  • Researchers aim to demonstrate that SP/MC is not only more acceptable due to its smaller dosage and better taste but also as effective as PEG for ensuring thorough bowel cleansing in outpatient settings.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates the effectiveness of endoscopic submucosal dissection (ESD) as a treatment for local residual or recurrent colorectal tumors, building on previous findings that showed favorable long-term outcomes for large colorectal neoplasms.
  • A multicenter prospective study involved 54 patients with local residual or recurrent tumors, where ESD successfully completed in 98.1% of cases and achieved high rates of en bloc and R0 resections.
  • The results indicated that ESD is a safe and effective option for managing these challenging tumors, with no significant short-term complications and no tumor recurrences during a median follow-up of 60 months.
View Article and Find Full Text PDF